|
[1]
|
Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study
Annals of Hematology,
2022
DOI:10.1007/s00277-022-04948-y
|
|
|
|
|
[2]
|
Insulin Therapy in Type 2 Diabetes Is Associated With Barriers to Activity and Worse Health Status: A Cross-Sectional Study in Primary Care
Frontiers in Endocrinology,
2021
DOI:10.3389/fendo.2021.573235
|
|
|
|
|
[3]
|
Minimally important difference and predictors of change in quality of life in type 2 diabetes: A community‐based survey in China
Diabetes/Metabolism Research and Reviews,
2018
DOI:10.1002/dmrr.3053
|
|
|
|
|
[4]
|
Minimally important difference and predictors of change in quality of life in type 2 diabetes: A community-based survey in China
Diabetes/Metabolism Research and Reviews,
2018
DOI:10.1002/dmrr.3053
|
|
|
|
|
[5]
|
Improved Treatment Satisfaction and Self-reported Health Status after Introduction of Basal-Supported Oral Therapy Using Insulin Glargine in Patients with Type 2 Diabetes: Sub-Analysis of ALOHA2 Study
Diabetes Therapy,
2015
DOI:10.1007/s13300-015-0111-5
|
|
|
|